» Articles » PMID: 19255064

Vitamin D-related Genes, Serum Vitamin D Concentrations and Prostate Cancer Risk

Abstract

We systematically investigated the association of 48 SNPS in four vitamin D metabolizing genes [CYP27A1, GC, CYP27B1 and CYP24A1] with serum 25-hydroxyvitamin D [25(OH)D] and 1,25-dihydroxyvitamin D [1,25(OH)(2)D] levels and the association of these SNPS and an additional 164 SNPS in eight downstream mediators of vitamin D signaling [VDR, RXRA, RXRB, PPAR, NCOA1, NCOA2, NCOA3 and SMAD3] with prostate cancer risk in the 749 incident prostate cancer cases and 781 controls of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. 25(OH)D (all cases and controls) and 1,25(OH)(2)D (a subset of 150 controls) levels were measured by radioimmunoassay and SNP data were genotyped as part of a genome-wide scan. Among investigated SNPS, only four tag SNPS in GC, the major serum 25(OH)D carrier, were associated with 25(OH)D levels; no SNPS were associated with 1,25(OH)(2)D levels. None of the 212 SNPS examined were associated with cancer risk overall. Among men in the lowest tertile of serum 25(OH)D (<48.9 nmol/l), however, prostate cancer risk was related to tag SNPS in or near the 3' untranslated region (UTR) of VDR, with the strongest association for rs11574143 [odds ratio (95% confidence interval) for risk allele carriers versus wild-type: 2.49 (1.51-4.11), P = 0.0007]; the genotype associations were null among men in tertile 2 and tertile 3. Results from the most comprehensive evaluation of serum vitamin D and its related genes to date suggest that tag SNPS in the 3' UTR of VDR may be associated with risk of prostate cancer in men with low vitamin D status.

Citing Articles

The Role of Vitamin D Metabolism Genes and Their Genomic Background in Shaping Cyclosporine A Dosage Parameters after Kidney Transplantation.

Kotowska K, Wojciuk B, Sienko J, Bogacz A, Stukan I, Drozdzal S J Clin Med. 2024; 13(16).

PMID: 39201108 PMC: 11355102. DOI: 10.3390/jcm13164966.


Vitamin D Deficiency at Diagnosis Increases All-Cause and Prostate Cancer-specific Mortality in Jamaican Men.

McGrowder D, Tulloch-Reid M, Coard K, McCaw-Binns A, Ferguson T, Aiken W Cancer Control. 2022; 29:10732748221131225.

PMID: 36180132 PMC: 9527998. DOI: 10.1177/10732748221131225.


Assessment of Specific Tumoral Markers, Inflammatory Status, and Vitamin D Metabolism before and after the First Chemotherapy Cycle in Patients with Lung Cancer.

Crintea A, Drugan C, Constantin A, Lupan I, Fekete Z, Silaghi C Biology (Basel). 2022; 11(7).

PMID: 36101414 PMC: 9312139. DOI: 10.3390/biology11071033.


Association Between Vitamin D Binding Protein Gene Polymorphism (rs7041), Vitamin D Receptor, and 25-Hydroxyvitamin D Serum Levels With Prostate Cancer in Kurdish Population in West of Iran.

Amiri M, Elieh Ali Komi D, Vaisi-Raygani A, Kiani A, Moradi M, Aliyari M Pathol Oncol Res. 2022; 28:1610246.

PMID: 36017197 PMC: 9395586. DOI: 10.3389/pore.2022.1610246.


Tipping the Balance: Vitamin D Inadequacy in Children Impacts the Major Gut Bacterial Phyla.

Singh P, Rawat A, Saadaoui M, Elhag D, Tomei S, Elanbari M Biomedicines. 2022; 10(2).

PMID: 35203487 PMC: 8869474. DOI: 10.3390/biomedicines10020278.


References
1.
Hollis B . Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol. 1997; 282:174-86. DOI: 10.1016/s0076-6879(97)82106-4. View

2.
Uitterlinden A, Fang Y, van Meurs J, Pols H, van Leeuwen J . Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338(2):143-56. DOI: 10.1016/j.gene.2004.05.014. View

3.
Hayes R, Sigurdson A, Moore L, Peters U, Huang W, Pinsky P . Methods for etiologic and early marker investigations in the PLCO trial. Mutat Res. 2005; 592(1-2):147-54. DOI: 10.1016/j.mrfmmm.2005.06.013. View

4.
Carlson C, Eberle M, Rieder M, Yi Q, Kruglyak L, Nickerson D . Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet. 2003; 74(1):106-20. PMC: 1181897. DOI: 10.1086/381000. View

5.
Kliewer S, Umesono K, Noonan D, HEYMAN R, Evans R . Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 1992; 358(6389):771-4. PMC: 6159883. DOI: 10.1038/358771a0. View